Chronic Hepatitis C in Saudi Arabia: Three Years Local Experience in a University Hospital
Authors
Hisham O Akbar1,*, Ahmad Al Ghamdi2, Faten Qattan2, Hind I Fallatah1, Maha Al Rumani2
1Department of Internal Medicine, King Abdul Aziz University Hospital, gihepa@yahoo.com, Saudi Arabia
2Molecular Biology Department, King Abdul Aziz University Hospital, Saudi Arabia
*Corresponding Author: Department of Internal Medicine, King Abdul Aziz University Hospital, P. O. Box: 80215 Jeddah 21589, gihepa@yahoo.com, Saudi Arabia. Tel: +96-626408435. Fax: +96-626408315. Email: gihepa@yahoo.com
Chronic hepatitis C (CHC) is a global infection. In Saudi Arabia, the prevalence of CHC is declining due to the implementation of a blood screening program. However, CHC still remains a leading cause of liver cirrhosis and hepatocellular carcinoma.
Objectives:
This is a retrospective study of CHC patients at the King Abdul Aziz University Hospital, Jeddah, Saudi Arabia.
Patients and Methods:
Out of a total of 291 CHC patients from the hepatology clinic at King Abdul Aziz University hospital, Jeddah, 279 patients were included in the present study. They were primarily male (152, 54.5%), with a mean age of 50.41 1.72 years. The majority of patients were either Saudi (108, 38.7%) or Egyptian (60, 21.5%). A total of 61 patients received combination treatment with pegylated interferon and ribavirin, and one patient with sickle-cell anemia received pegylated INF monotherapy. Demographic, clinical and laboratory features of the CHC patients, and their responses to treatment were studied.
Results:
Decompensated cirrhosis was documented in 60 patients (21.5%), and hepatocellular carcinoma in 14 (5%). The mean level of serum alanine aminotransferase was 83.6 231 u/L. The predominant genotype among the 70 patients tested, was genotype 4, followed by genotype 1 (39 and 18 patients, respectively). The sustained viral response (SVR) rate was 82.99%. The main predictive factors for SVR were baseline HCV viral load and rapid virologic response (RVR). The mean duration of follow-up was 4.2 .85 years. There were 24 patients who had liver disease-related mortality.
Conclusions:
our data showed that 22% of CHC patients progress to cirrhosis and another 22% had treatment. Liver related mortality was more common in patients with advanced cirrhosis.
How to Cite:Akbar H, Al Ghamdi A, Qattan F, Fallatah H, Al Rumani M. Chronic Hepatitis C in Saudi Arabia: Three Years Local Experience in a University Hospital. Hepat Mon. 2012;12(9):6178. doi: https://doi.org/10.5812/hepatmon.6178
Alswat KA, Sanai FM, Altuwaijri M, Albenmousa A, Almadi M, et al. Clinical Characteristics of Patients with Hepatocellular Carcinoma in a Middle Eastern Population. Hepat Mon. 2013;13(5):e7612. doi: https://doi.org/10.5812/hepatmon.7612
Bokharaei-Salim F, Keyvani H, Monavari SH, Alavian SM, Fakhim S, et al. Distribution of Hepatitis C Virus Genotypes among Azerbaijani Patients in Capital City of Iran-Tehran. Hepat Mon. 2013;13(9):e13699. doi: https://doi.org/10.5812/hepatmon.13699
Bakhshipour A, Sargolzaie N, Kiani M, Barazesh F. Hepatitis C Virus Genotypes in Patients Referred to Educational Hospitals in Zahedan (2009 ‒ 2013). Int J Infect. 2016;3(2):e34666. doi: https://doi.org/10.5812/iji.14747
Nazer MR, Beiranvand B, Obeidavi Z, Beiki O. Prevalence of hepatitis C genotypes in patients with hepatitis C in Lorestan province (2009-2013). J Kermanshah Univ Med Sci. 2014;18(2):e74169. doi: https://doi.org/10.22110/jkums.v18i2.1358
Ebrahimzadeh P, Haghshenas M, Babamahmoodi F. The Prevalence of Hepatitis C Virus Genotypes in Mazandaran Province, Iran. Jundishapur J Microbiol. 2017;10(4):e40750. doi: https://doi.org/10.5812/jjm.40750